Form 8-K - Current report:
SEC Accession No. 0001193125-25-237998
Filing Date
2025-10-14
Accepted
2025-10-14 07:00:46
Documents
63
Period of Report
2025-10-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lrmr-20251014.htm   iXBRL 8-K 45204
2 EX-99.1 lrmr-ex99_1.htm EX-99.1 56353
3 GRAPHIC lrmr-ex99_1s1.jpg GRAPHIC 188275
4 GRAPHIC lrmr-ex99_1s2.jpg GRAPHIC 712575
5 GRAPHIC lrmr-ex99_1s3.jpg GRAPHIC 666876
6 GRAPHIC lrmr-ex99_1s4.jpg GRAPHIC 441654
7 GRAPHIC lrmr-ex99_1s5.jpg GRAPHIC 331337
8 GRAPHIC lrmr-ex99_1s6.jpg GRAPHIC 356264
9 GRAPHIC lrmr-ex99_1s7.jpg GRAPHIC 145610
10 GRAPHIC lrmr-ex99_1s8.jpg GRAPHIC 440797
11 GRAPHIC lrmr-ex99_1s9.jpg GRAPHIC 294299
12 GRAPHIC lrmr-ex99_1s10.jpg GRAPHIC 285006
13 GRAPHIC lrmr-ex99_1s11.jpg GRAPHIC 343128
14 GRAPHIC lrmr-ex99_1s12.jpg GRAPHIC 324586
15 GRAPHIC lrmr-ex99_1s13.jpg GRAPHIC 400788
16 GRAPHIC lrmr-ex99_1s14.jpg GRAPHIC 377617
17 GRAPHIC lrmr-ex99_1s15.jpg GRAPHIC 485943
18 GRAPHIC lrmr-ex99_1s16.jpg GRAPHIC 139561
19 GRAPHIC lrmr-ex99_1s17.jpg GRAPHIC 466499
20 GRAPHIC lrmr-ex99_1s18.jpg GRAPHIC 239194
21 GRAPHIC lrmr-ex99_1s19.jpg GRAPHIC 267474
22 GRAPHIC lrmr-ex99_1s20.jpg GRAPHIC 376017
23 GRAPHIC lrmr-ex99_1s21.jpg GRAPHIC 270994
24 GRAPHIC lrmr-ex99_1s22.jpg GRAPHIC 179821
25 GRAPHIC lrmr-ex99_1s23.jpg GRAPHIC 411533
26 GRAPHIC lrmr-ex99_1s24.jpg GRAPHIC 148327
27 GRAPHIC lrmr-ex99_1s25.jpg GRAPHIC 405030
28 GRAPHIC lrmr-ex99_1s26.jpg GRAPHIC 319761
29 GRAPHIC lrmr-ex99_1s27.jpg GRAPHIC 285098
30 GRAPHIC lrmr-ex99_1s28.jpg GRAPHIC 398137
31 GRAPHIC lrmr-ex99_1s29.jpg GRAPHIC 347334
32 GRAPHIC lrmr-ex99_1s30.jpg GRAPHIC 326135
33 GRAPHIC lrmr-ex99_1s31.jpg GRAPHIC 133617
34 GRAPHIC lrmr-ex99_1s32.jpg GRAPHIC 357390
35 GRAPHIC lrmr-ex99_1s33.jpg GRAPHIC 401999
36 GRAPHIC lrmr-ex99_1s34.jpg GRAPHIC 317760
37 GRAPHIC lrmr-ex99_1s35.jpg GRAPHIC 322433
38 GRAPHIC lrmr-ex99_1s36.jpg GRAPHIC 326108
39 GRAPHIC lrmr-ex99_1s37.jpg GRAPHIC 224715
40 GRAPHIC lrmr-ex99_1s38.jpg GRAPHIC 139506
41 GRAPHIC lrmr-ex99_1s39.jpg GRAPHIC 441785
42 GRAPHIC lrmr-ex99_1s40.jpg GRAPHIC 346186
43 GRAPHIC lrmr-ex99_1s41.jpg GRAPHIC 399416
44 GRAPHIC lrmr-ex99_1s42.jpg GRAPHIC 417095
45 GRAPHIC lrmr-ex99_1s43.jpg GRAPHIC 182480
46 GRAPHIC lrmr-ex99_1s44.jpg GRAPHIC 475506
47 GRAPHIC lrmr-ex99_1s45.jpg GRAPHIC 391721
48 GRAPHIC lrmr-ex99_1s46.jpg GRAPHIC 477440
49 GRAPHIC lrmr-ex99_1s47.jpg GRAPHIC 139362
50 GRAPHIC lrmr-ex99_1s48.jpg GRAPHIC 384555
51 GRAPHIC lrmr-ex99_1s49.jpg GRAPHIC 136701
52 GRAPHIC lrmr-ex99_1s50.jpg GRAPHIC 368970
53 GRAPHIC lrmr-ex99_1s51.jpg GRAPHIC 125808
54 GRAPHIC lrmr-ex99_1s52.jpg GRAPHIC 337843
  Complete submission text file 0001193125-25-237998.txt   23939190

Data Files

Seq Description Document Type Size
55 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lrmr-20251014.xsd EX-101.SCH 23893
65 EXTRACTED XBRL INSTANCE DOCUMENT lrmr-20251014_htm.xml XML 4533
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36510 | Film No.: 251389571
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)